Registered Kenya · PPB

APLUTER INJECTION

α-β ARTEETHER

CTD3576 ARTEETHER 150MG PER 2ML GENERIC/BIOSIMILARS

What it does

Arteether is a medication used to treat severe malaria, a serious infection caused by parasites.

Commonly used for: severe malaria, falciparum malaria

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
CTD3576
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
α-β ARTEETHER
Strength
-
Pack size
BOX OF 3 AMPOULES OF 2 ML EACH.
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Dawa
Applicant / LTR
MEDISEL KENYA LIMITED
Country of origin
FOREIGN
Manufacturer location
Baba Dogo Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:19:48 · updated 2026-07-26 09:19:06

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Arteether is a medication used to treat severe malaria, a serious infection caused by parasites.

What it treats

  • severe malaria
  • falciparum malaria

How it works

Arteether works by killing the malaria parasites in the blood, helping to reduce the infection and symptoms.

Who it's for

Arteether is for people diagnosed with severe malaria, especially when other treatments may not be suitable.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: arteether

BNF-referenced

Arteether is an antimalarial medication derived from artemisinin, used primarily for the treatment of uncomplicated Plasmodium falciparum malaria. It is administered intramuscularly and is known for its rapid action against malaria parasites, particularly in cases where oral treatment is not feasible. Arteether is effective in reducing the parasite load, thus aiding in the recovery from malaria.

Indications

  • Uncomplicated Plasmodium falciparum malaria
  • Severe malaria when intravenous treatment is not possible

Dosage

Children: Refer to BNF for Children for specific dosing guidelines.

Adults: Refer to BNF for specific dosing guidelines.

Mechanism of action

Arteether exerts its antimalarial effects through the production of reactive oxygen species (ROS) that damage the parasites. The drug interacts with the heme moiety in the malaria parasite, leading to the generation of free radicals that are toxic to the parasite. This mechanism disrupts cellular function and ultimately results in the death of the malaria organism.

Pharmacodynamics

The pharmacodynamics of arteether involve rapid absorption and action against the malaria parasites. It is particularly effective against the asexual stages of the Plasmodium species. Arteether demonstrates a strong affinity for the parasites, leading to a quick reduction in parasitemia and alleviation of malaria symptoms. Its efficacy is enhanced when used in conjunction with other antimalarials.

Pharmacokinetics

Arteether is administered intramuscularly, leading to rapid systemic absorption. The drug is metabolized primarily in the liver, with its metabolites contributing to the antimalarial action. Arteether has a relatively short half-life, which necessitates careful dosing to maintain effective plasma concentrations. Renal and hepatic function can influence the pharmacokinetics of arteether, and dose adjustments may be required in patients with impaired function.

Pregnancy

There is limited data on the use of arteether in pregnant women. Its use should be considered only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Arteether is excreted in breast milk. Caution should be exercised when arteether is administered to a nursing mother.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Arteether injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: arteether

PubChem CID 3000469

Molecular formula: C17H28O5

Mechanism of action

A 2025 systematic review notes that Arteether's pharmacological activity is antimalarial.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

Malawi 1 product